Home/Filings/4/0001493152-20-010852
4//SEC Filing

Slosman Marvin 4

Accession 0001493152-20-010852

CIK 0001433607other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 1:30 PM ET

Size

9.2 KB

Accession

0001493152-20-010852

Insider Transaction Report

Form 4
Period: 2020-06-05
Slosman Marvin
DirectorCEO and President
Transactions
  • Purchase

    Common Stock

    2020-06-05$0.45/sh+55,550$24,998237,931 total
  • Purchase

    Warrants

    2020-06-05$0.45/sh+55,550$24,99855,550 total
    Exercise: $0.49From: 2020-06-05Exp: 2025-06-02Common Stock (55,550 underlying)
Holdings
  • Options (right to buy)

    Exercise: $1.10Exp: 2030-01-02Common Stock (60,794 underlying)
    60,794
Footnotes (4)
  • [F1]The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 55,550 shares of common stock and 55,000 warrants to purchase common stock together, as part of 55,000 units, at a purchase price of $0.45 per unit.
  • [F2]182,381 of these shares of common stock represent restricted stock units ("RSUs"), which vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the Reporting Person's continued service.
  • [F3]The Reporting Person has not engaged in any reportable transactions with respect to the derivative securities of the Issuer reported in this row and is including his ownership of these securities for informational purposes only in this Form 4.
  • [F4]These stock options vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the Reporting Person's continued service.

Documents

1 file

Issuer

InspireMD, Inc.

CIK 0001433607

Entity typeother

Related Parties

1
  • filerCIK 0001796908

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 1:30 PM ET
Size
9.2 KB